404 related articles for article (PubMed ID: 18972629)
1. Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction.
Greif M; Zwermann L; Reithmann C; Weis M
Acute Card Care; 2008; 10(3):185-90. PubMed ID: 18972629
[TBL] [Abstract][Full Text] [Related]
2. Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction.
Christoph A; Prondzinsky R; Russ M; Janusch M; Schlitt A; Lemm H; Reith S; Werdan K; Buerke M
Acute Card Care; 2008; 10(1):49-57. PubMed ID: 17924229
[TBL] [Abstract][Full Text] [Related]
3. Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.
Russ MA; Prondzinsky R; Carter JM; Schlitt A; Ebelt H; Schmidt H; Lemm H; Heinroth K; Soeffker G; Winkler M; Werdan K; Buerke M
Crit Care Med; 2009 Dec; 37(12):3017-23. PubMed ID: 19661807
[TBL] [Abstract][Full Text] [Related]
4. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.
Rokyta R; Pechman V
Neuro Endocrinol Lett; 2006; 27(1-2):121-7. PubMed ID: 16648778
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance.
Tsagalou EP; Kanakakis J; Anastasiou-Nana MI; Drakos SG; Ntalianis AS; Malliaras K; Lazaris N; Katsaros F; Nanas JN
Acute Card Care; 2009; 11(2):99-106. PubMed ID: 19353405
[TBL] [Abstract][Full Text] [Related]
6. Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.
García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ
J Clin Pharmacol; 2005 Jun; 45(6):704-8. PubMed ID: 15901754
[No Abstract] [Full Text] [Related]
7. Early 'in-lab' use of levosimendan in patients with cardiogenic shock unsuitable for intra-aortic balloon pump counterpulsation.
Summaria F; Mustilli M; Sette A; Lanzillo C; Romagnoli E
Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):28-31. PubMed ID: 24492986
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction.
Fuhrmann JT; Schmeisser A; Schulze MR; Wunderlich C; Schoen SP; Rauwolf T; Weinbrenner C; Strasser RH
Crit Care Med; 2008 Aug; 36(8):2257-66. PubMed ID: 18664782
[TBL] [Abstract][Full Text] [Related]
9. Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty.
Samimi-Fard S; García-González MJ; Domínguez-Rodríguez A; Abreu-González P
Int J Cardiol; 2008 Jul; 127(2):284-7. PubMed ID: 17643519
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.
Russ MA; Prondzinsky R; Christoph A; Schlitt A; Buerke U; Söffker G; Lemm H; Swyter M; Wegener N; Winkler M; Carter JM; Reith S; Werdan K; Buerke M
Crit Care Med; 2007 Dec; 35(12):2732-9. PubMed ID: 17893627
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial.
Prondzinsky R; Unverzagt S; Russ M; Lemm H; Swyter M; Wegener N; Buerke U; Raaz U; Ebelt H; Schlitt A; Heinroth K; Haerting J; Werdan K; Buerke M
Shock; 2012 Apr; 37(4):378-84. PubMed ID: 22266974
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan in patients with acute myocardial ischaemia undergoing emergency surgical revascularization.
Lehmann A; Kiessling AH; Isgro F; Zeitler C; Thaler E; Boldt J
Eur J Anaesthesiol; 2008 Mar; 25(3):224-9. PubMed ID: 17892614
[TBL] [Abstract][Full Text] [Related]
13. Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.
García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ; Abreu-González P; Muñoz MB
Eur J Heart Fail; 2006 Nov; 8(7):723-8. PubMed ID: 16492404
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W
Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
[TBL] [Abstract][Full Text] [Related]
15. [Successful use of levosimendan in a patient with cardiogenic shock complicating acute myocardial infarction].
Mustapha F; Moufida H; Nedia B; Anis L; Iheb L; Habib H
Tunis Med; 2005 Oct; 83(10):635-7. PubMed ID: 16370217
[TBL] [Abstract][Full Text] [Related]
16. Levosimendan in the treatment of cardiogenic shock.
Buerkem B; Lemm H; Krohe K; Dietz S; Raaz U; Buerke U; Russ M; Schlitt A; Werdan K
Minerva Cardioangiol; 2010 Aug; 58(4):519-30. PubMed ID: 20938415
[TBL] [Abstract][Full Text] [Related]
17. Levosimendan in patients with cardiogenic shock undergoing surgical revascularization: a case series.
Lehmann A; Lang J; Boldt J; Isgro F; Kiessling AH
Med Sci Monit; 2004 Aug; 10(8):MT89-93. PubMed ID: 15278007
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan: a promising treatment for myocardial stunning?
Ellger BM; Zahn PK; Van Aken HK; Schmidt C; Brussel T
Anaesthesia; 2006 Jan; 61(1):61-3. PubMed ID: 16409345
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction.
De Luca L; Proietti P; Celotto A; Bucciarelli-Ducci C; Benedetti G; Di Roma A; Sardella G; Genuini I; Fedele F
Am Heart J; 2005 Sep; 150(3):563-8. PubMed ID: 16169341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]